The Decoquinate-Based
Products Market report discusses the
primary market growth drivers and challenges that the vendors and the market as
a whole face and provides an overview of the key trends emerging in the market.
This study also shows about the industry size of different segments and their
growth aspects along with key leading countries in Americas, Asia-Pacific,
Europe, the Middle East, and Africa regions.
Decoquinate (ethyl 6-decoxy-7-ethoxy-4-oxo-1H-quinoline-3-carboxylate)
is an antiprotozoal agent. It acts against coccidia parasites and is thus known
as a coccidiostat. Decoquinate-based products are majorly used in veterinary
medicine. The global decoquinate-based products market is segmented on the
basis of type of formulation, and geography.
Decoquinate acts on the sporozoite stage of a coccidian parasite’s
lifecycle. The sporozoite can penetrate the host’s intestinal call and prevents
their further development, which necessitates the use of antiprotozoal
substances. Decoquinate has low toxicity and is administered orally to a wide
range of mammalian and avian species.
Download Free Sample Report Now @ https://www.millioninsights.com/industry-reports/decoquinate-based-products-market/request-sample
Main features of the report:
·
To provide detailed analysis of
the market structure along with forecast of the various segments and
sub-segments of the global Decoquinate-Based Products Market.
·
A complete backdrop analysis,
which includes an assessment of the parent market
·
Important changes in market
dynamics
·
Market segmentation up to the
second or third level
·
To provide country level
analysis of the market for segment by application, product type and
sub-segments.
·
To provide strategic profiling
of key players in the market, comprehensively analyzing their core
competencies, and drawing a competitive landscape for the market.
·
Track and analyze competitive
developments such as joint ventures, strategic alliances, mergers and
acquisitions, new product developments, and research and developments in the
global Decoquinate-Based Products Market.
·
Emerging niche segments and
regional markets
·
An objective assessment of the
trajectory of the industry.
Various studies conducted on decoquinate-based products suggest that the
drug is readily tolerated by several target species including cattle and lambs.
On the other hand, studies conducted on rats and dogs showed minor changes in
food consumption, feed conversion, subdued behavior, and changes in body weight
and organ weight. In conclusion, though there may be a minor risk posed by
decoquinate-based products, the protection it provides against coccidian
parasites comfortably outweighs it.
On the basis of type of formulation, the global decoquinate-based
products market is segmented into powder, tablet, and nanoparticles and so on.
“Powdered decoquinate” dominates the global decoquinate-based products industry
owing to its ease of usage. Powdered decoquinate-based products can easily be
added to animal feed, which also helps the drug get absorbed into the animal’s
body at a rapid rate.
However, nanoscale decoquinate-based products comprise the fastest
growing segment of the global decoquinate-based products market due to the
added advantages nanoparticles provide over powders. The smaller size of
nanoparticles means they can be absorbed into the animal’s body even quicker
than powders. The increased overall surface area of nanoscale decoquinate-based
products also means they are more reactive and more likely to encounter a
coccidian parasite. On the basis of geography, the global decoquinate-based
products market is segmented into Asia Pacific, North America, Europe, Latin
America and Middle East & Africa.
North America and Europe currently dominate the global decoquinate-based
products market due to the strong economic conditions and the large population
of cattle in these regions. The Europe market for decoquinate-based products is
driven by the rising demand from Switzerland which is known for its large dairy
industry. Additionally, several
governments in North America and Europe have also set up regulatory agencies
which have also been instrumental in the growth of the global decoquinate-based
products market. These government bodies provide funds for developing novel
veterinary biologics and animal health products such as antibodies, vaccines,
diagnostic kits which are used for the prevention, diagnosis and treatment of
infectious diseases in animals.
The Asia Pacific market for decoquinate-based products is also growing
rapidly due to the increasing awareness about the benefits of decoquinate among
cattle and poultry breeders. The key players of global decoquinate-based
products market are Alpharma, Pfizer Inc., 3 nitro, ChlorMax, Albac,
Lincomusin, Laboratories Biove’s acti decocci and lacto decocci, Sogeval
Laboratories Rumicox, Pharmacia & Upjihn Company’s Lincomix and Qualian’s
Ucamix V decoquinate.
Know
More Insights @ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment